杭州泰格医药科技股份有限公司（泰格医药，股票代码：03347）于2026年6月10日公告，，公司在深圳证券交易所回购股份155.07万股，占当日回购前已发行股本约0.2118%。本次回购的每股价格区间为人民币38.22元至39.50元，合计支付约6006.56万元人民币（折合60,065,628.58元）。
回购完成后，公司已发行股本变更为730,466,770股，库存股份数量增至7,434,480股，总股本保持在737,901,250股。公司确认已遵守香港联合交易所《主板上市规则》的相关规定，并表示2026年5月19日呈交香港联交所的说明函件所载资料无重大变动。
公告由董事叶小平签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.